WHWK
Whitehawk Therapeutics
$3.70
−$0.01 (−0.27%)Jul 27, 2026
Key metrics
The numbers that frame WHWK today
- Market cap
- $182.97M
- P/E (TTM)
- -1.6
- EV / FCF
- -1.4
- ROIC
- -141.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.57
- 52wk High
- $5.50
Growth
Revenue and earnings trend for WHWK
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about WHWK
Is Whitehawk Therapeutics a good buy?
Hold. Whitehawk Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Whitehawk Therapeutics is selling at a very high price.
What is the market capitalization of WHWK?
Whitehawk Therapeutics's market capitalization is $182.97M.
What is the P/E ratio for WHWK stock?
Whitehawk Therapeutics's current P/E ratio is -1.6.
What is the 52-week high for WHWK stock?
The 52-week high for Whitehawk Therapeutics is $5.50. The current close of $3.70 is 32.7% below that high.
What is the 52-week low for WHWK stock?
The 52-week low for Whitehawk Therapeutics is $1.57. The current close of $3.70 is 135.7% above that low.
Does WHWK stock pay dividends?
Whitehawk Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for WHWK?
Whitehawk Therapeutics's Debt / Equity ratio is 0.